Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: A prospective study

Pediatric Hematology and Oncology

Volumn 27, Issue 7, 2010, Pages 529-533

  Hamidieh, Amir Ali ^a   Hamedani, Ravak ^b   Hadjibabaie, Molouk ^a,b   Amini, Mohsen ^b   Sadrai, Sima ^b   Ghavamzadeh, Ardeshir ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

anticonvulsants; busulfan; hematopoietic stem cell transplantation; lorazepam

Indexed keywords

BUSULFAN; CYCLOSPORIN; GRANISETRON; LORAZEPAM; METHOTREXATE; PROMETHAZINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; AGITATION; ALBERS SCHOENBERG DISEASE; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DIZZINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EXCITEMENT; FANCONI ANEMIA; FEMALE; HALLUCINATION; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LOW DRUG DOSE; MALE; PRESCHOOL CHILD; PROPHYLAXIS; PROSPECTIVE STUDY; RESPIRATION DEPRESSION; SCHOOL CHILD; SEDATION; SEIZURE; SIDE EFFECT; THALASSEMIA; URINE INCONTINENCE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICONVULSANTS; BUSULFAN; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LORAZEPAM; MALE; OSTEOPETROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; SEIZURES; THALASSEMIA;

EID: 77957220407     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.496895     Document Type: Article

References (15)

1. Tutschka PJ, Santon GW. Bone marrow transplantation in the busulfan-treated rat, III: relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients. Transplantation. 1977;24:52-62.
2. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983;309: 1347-1353. (Pubitemid 14246556)
3. Vassal, G, Gouyette A, Hartmann O, et al. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother. Pharmacol. 1989;24:386-390. (Pubitemid 19239318)
4. Santos GW. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation. Bone Marrow Transplant. 1989;4(Suppl 1):236-1139
5. Vassal G, Deroussent A, Hartmann O, et al. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res. 1990;50:6203-6207. (Pubitemid 20323675)
6. Hassan M, Oberg G, Bjorkholm M, et al. Influence of prophylactic anticonvulsant therapy on highdose busulfan kinetics. Cancer Chemother Pharmacol. 1993;33:181-186. (Pubitemid 23361064)
7. Chan KW, Mullen CA, Worth LL, et al. Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant. 2002;29:963-965.
8. Hobbs JR, Hugh-Jones K, Shaw PJ, et al. Engraftment rates related to busulfan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children. Bone Marrow Transplant. 1986;1:201-208. (Pubitemid 18048962)
9. Lin KH, Lin KS, Freig SA. Marrow transplantation for thalassemia. Bone Marrow Transplant. 1986;1:115-120.
10. Bishop JB, Wassom JS. Toxicological review of busulfan (Myleran). Mutat Res. 1986;168:15-45.
11. Marcus RE, Goldman JM. Convulsions due to high-dose busulfan. Lancet. 1984;2:1463.
12. Neef C, De Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther. 1988;43:372-375.
13. Shaw PJ, Scharping CE, Brian RJ, et al. Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia. Blood. 1994;84:2357-2362.
14. MeloniG,Nasta L, Pinto RM, et al. Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients. Haematologica. 1995;80:532-534.
15. Caselli D, Ziino O, Bartoli A, et al. Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan. Bone Marrow Transplant. 2008;42: 135-136.